Don't miss our holiday offer - up to 50% OFF!
TB500 – 5mg (10 vials)
$94.00
TB-500 – 5mg – 10 Vials
TB-500 is a commercial peptide designation commonly associated with thymosin beta-4-related research. It has attracted scientific interest in studies involving actin regulation, cell movement, and cellular processes. This listing describes a 5mg, 10-vial presentation. Confirm the exact peptide sequence, formulation, and whether 5mg refers to each
TB-500 – 5mg – 10 Vials
Product Overview
TB-500 is a commercial peptide designation commonly associated with research involving thymosin beta-4. Thymosin beta-4 is a naturally occurring peptide studied for its role in actin regulation, a process involved in cell structure and movement.
Commercial products labeled TB-500 may differ in their exact composition and peptide sequence. The identity of this particular product should therefore be confirmed through reliable manufacturer or supplier documentation.
Product Details
- Product Name: TB-500
- Listed Strength: 5mg
- Package Quantity: 10 vials
- Product Category: Synthetic Peptide
- Research Area: Thymosin beta-4-related peptide research
- Exact Peptide Sequence: Confirm with supplier
- Manufacturer: Confirm with supplier
- Formulation: Confirm with supplier
- Storage Requirements: Follow verified manufacturer documentation
Scientific Background
Thymosin beta-4 is involved in actin regulation, which contributes to cellular structure and movement. Scientific research has explored its relationship with different cellular and tissue-related processes.
However, findings involving thymosin beta-4 should not automatically be attributed to every commercial product labeled TB-500. The exact ingredient identity and sequence should be established before making specific scientific claims.
Product Verification
Before publishing or distributing this product, confirm:
- Whether 5mg refers to each vial or the entire package
- Exact peptide identity and amino acid sequence
- Manufacturer identity and product labeling
- Batch identification and available quality documentation
- Storage and handling requirements
- Applicable regulatory status and distribution requirements
Important Safety and Regulatory Information
TB-500 should be treated as an investigational research compound. Its safety and effectiveness for therapeutic human use have not been established sufficiently to present it as an approved treatment.
This description is for product identification and general research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Avoid unsupported claims about healing, injury recovery, or other clinical benefits. Verify the product’s identity and regulatory status before publication.







Reviews
There are no reviews yet.